EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.595
https://www.valueinhealthjournal.com/article/S1098-3015(23)03725-7/fulltext
Title :
EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03725-7&doi=10.1016/j.jval.2023.09.595
First page :
Section Title :
Open access? :
No
Section Order :
10087